Capricor Therapeutics Inc (CAPR)

Sector:
REAL ESTATE
Industry:
REAL ESTATE MANAGEMENT & DEVELOPMENT
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Linda Marba¡n
Employees:
18
8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA 90211
(310) 358-3200

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.

Data derived from most recent annual or quarterly report
Market Cap 82.129 Million Shares Outstanding24.298 Million Avg 30-day Volume 93.539 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue408.1193 Debt to Equity0.137 EBITDA-23.321 Million
Price to Book Value3.3799 Operating Margin-11568.334299999999 Enterprise Value28.332 Million
Current Ratio4.163 EPS Growth0 Quick Ratio4.073
1 Yr BETA 0.866 52-week High/Low 6.22 / 2.56 Profit Margin-11117.4394
Operating Cash Flow Growth186.8535 Altman Z-Score-1.6175 Free Cash Flow to Firm 8.608 Million
Earnings Report2022-08-11
View SEC Filings from CAPR instead.

View recent insider trading info

Capricor Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CAPR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CAPR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

43.4 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MANZO LOUIS

16,595 2022-03-31 2

DUNBAR GEORGE W JR

9,155 2022-03-29 2

COLLIER EARL M JR

0 2022-03-08 2

MUSKET DAVID B

84,080 2022-01-03 2

LITVACK FRANK

359,632 2022-01-03 1

MARBAN LINDA CHIEF EXECUTIVE OFFICER

377,830 2022-01-03 1

KRASNEY KAREN EVP, GENERAL COUNSEL

84,080 2022-01-03 1

BERGMANN ANTHONY CHIEF FINANCIAL OFFICER

166,980 2022-01-03 1

SABAR KARIMAH ES

7,690 2022-01-03 3

ASCHEIM DEBORAH CHIEF MEDICAL OFFICER

  • Officer
 0 2018-07-24 0

KAZAM JOSHUA A

  • Director
 0 2018-01-02 0

SMITH RACHEL VICE PRESIDENT OF R&D

  • Officer
 0 2018-01-02 0

CEDARS SINAI MEDICAL CENTER

  • 10% Owner
 4,049,959 2017-05-09 0

MARBAN EDUARDO

  • 10% Owner
 3,307,863 2016-12-31 0

GRASMICK LOUIS J

  • Director
 1,182,439 2016-03-16 0

GERSHELL LELAND CHIEF FINANCIAL OFFICER

  • Officer
 3,150 2016-03-16 0

ST. JOHN EDWARD A.

EDWARD ST. JOHN, LLC

  • 10% Owner
 4,750,185 2016-03-16 0

SCHAFER GREGORY W

  • Director
 0 2015-03-03 0

HAMER ANDREW WARWICK VP OF MEDICAL AFFAIRS

  • Officer
 0 2015-03-03 0

DAVIES ANTHONY CHIEF TECHNOLOGY OFFICER

  • Officer
 0 2013-11-20 0

ST. JOHN EDWARD A.

MD BTI, LLC

EDWARD ST. JOHN, LLC

  • 10% Owner
 5,047,221 2013-11-20 0

HORTON DARLENE P PRESIDENT & CEO

  • Officer
  • Director
 0 2012-08-06 0

KASH PETER M

  • Director
 2,258,327 2011-07-18 0

LIEU HSIAO VP, CLINICAL RESEARCH

  • Officer
 100 2011-05-26 0

GRANADILLO PEDRO P

  • Director
 27,588 2011-05-10 0

BELLDEGRUN ARIE

  • Director
 711,420 2011-05-10 0

MIEYAL PAUL A

  • Director
 0 2011-05-10 0

EVANS DARON CHIEF FINANCIAL OFFICER

  • Officer
 23,752 2011-04-18 0

BREWER RICHARD B EXECUTIVE CHAIRMAN

  • Officer
  • Director
 0 2010-07-26 0

TANEN DAVID M

  • Director
 No longer subject to file 2009-12-31 0

STRUMPH PETER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2009-01-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MANZO LOUIS

2022-04-01 17:00:22 -0400 2022-03-31 F 11,309 $3.43 d 16,595 direct -1.6129 -5.1075 -15.3226 0.0 1 -22.3118 28

MANZO LOUIS

2022-04-01 17:00:22 -0400 2022-03-31 M 27,904 $1.39 a 27,904 direct -1.6129 -5.1075 -15.3226 0.0 1 -22.3118 28

MANZO LOUIS

2022-04-01 17:00:22 -0400 2022-03-31 M 15,455 d 0 direct

MANZO LOUIS

2022-04-01 17:00:22 -0400 2022-03-31 M 12,449 d 0 direct

DUNBAR GEORGE W JR

2022-03-31 17:00:20 -0400 2022-03-29 F 6,300 $3.41 d 9,155 direct 3.6212 -2.2284 -13.9276 3.6212 2 -19.4986 29

DUNBAR GEORGE W JR

2022-03-31 17:00:20 -0400 2022-03-29 M 15,455 d 0 direct

DUNBAR GEORGE W JR

2022-03-31 17:00:20 -0400 2022-03-29 M 15,455 $1.39 a 15,455 direct 3.6212 -2.2284 -13.9276 3.6212 2 -19.4986 29

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 22:15:03 UTC -5.5337 6.3537 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 21:45:03 UTC -5.526 6.346 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 21:15:03 UTC -5.526 6.346 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 20:45:03 UTC -5.5169 6.3369 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 20:15:03 UTC -5.5169 6.3369 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 19:45:03 UTC -5.5169 6.3369 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 19:15:03 UTC -5.5169 6.3369 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 18:45:04 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 18:15:03 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 17:45:03 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 17:15:03 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 16:45:04 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 16:15:03 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 15:45:03 UTC -5.5332 6.3532 850000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 15:15:03 UTC -5.5332 6.3532 750000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 14:45:03 UTC -5.2996 6.1196 750000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 14:15:03 UTC -5.2996 6.1196 750000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 13:45:05 UTC -5.2996 6.1196 750000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 13:15:03 UTC -5.2996 6.1196 700000
CAPRICOR THERAPEUTICS INC CAPR 2022-05-26 12:45:03 UTC -5.2996 6.1196 700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CAPR -6100.0 shares, $-17873.0 2021-12-31 N-PORT

Elevate your investments